Back
  1. Home
  2. Profile of Sofian Ringlet (ULiège)
Profil

Ringlet Sofian

GIGA Neurosciences - Neurophysiology

Département des sciences biomédicales et précliniques > GIGA

Pharmacologie

See author's contact details
ORCID
0000-0001-7280-9739
Main Referenced Co-authors
Engel, Dominique  (2)
Jehasse, Kevin  (2)
Lakaye, Bernard  (2)
Liégeois, Jean-François  (2)
Massotte, Laurent  (2)
Main Referenced Keywords
dopamine neuron (1); Dopaminergic Neurons (1); Ion Channels (1); Pacemaking (1); pacemaking (1);
Main Referenced Unit & Research Centers
Giga Neurosciences - ULiège [BE] (1)
Main Referenced Disciplines
Pharmacy, pharmacology & toxicology (1)
Anatomy (cytology, histology, embryology...) & physiology (1)
Biochemistry, biophysics & molecular biology (1)
Neurosciences & behavior (1)

Publications (total 4)

The most downloaded
284 downloads
Jehasse, K., Massotte, L., Hartmann, S., Vitello, R., Ringlet, S., Vitello, M., Chua, H. C., Pless, S., Engel, D., Liégeois, J.-F., Lakaye, B., Roeper, J., & Seutin, V. (01 October 2021). The gating pore blocker 1-(2,4-xylyl)guanidinium selectively inhibits pacemaking of midbrain dopaminergic neurons. Neuropharmacology, 197, 1-15. doi:10.1016/j.neuropharm.2021.108722 https://hdl.handle.net/2268/267117

The most cited

2 citations (Scopus®)

Jehasse, K., Massotte, L., Hartmann, S., Vitello, R., Ringlet, S., Vitello, M., Chua, H. C., Pless, S., Engel, D., Liégeois, J.-F., Lakaye, B., Roeper, J., & Seutin, V. (01 October 2021). The gating pore blocker 1-(2,4-xylyl)guanidinium selectively inhibits pacemaking of midbrain dopaminergic neurons. Neuropharmacology, 197, 1-15. doi:10.1016/j.neuropharm.2021.108722 https://hdl.handle.net/2268/267117

Ringlet, S., & Engel, D. (2022). Identification of the endogenous co-agonist of NMDA receptor in dopamine neurons from the substantia nigra [Paper presentation]. Belgian Society of Physiology and Pharmacology, Brussels, Belgium.

Jehasse, K., & Ringlet, S. (2022). Mechanisms controlling the excitability of midbrain dopaminergic neurons [Paper presentation]. Dopamine meeting 2022.

Jehasse, K., Massotte, L., Hartmann, S., Vitello, R., Ringlet, S., Vitello, M., Chua, H. C., Pless, S., Engel, D., Liégeois, J.-F., Lakaye, B., Roeper, J., & Seutin, V. (01 October 2021). The gating pore blocker 1-(2,4-xylyl)guanidinium selectively inhibits pacemaking of midbrain dopaminergic neurons. Neuropharmacology, 197, 1-15. doi:10.1016/j.neuropharm.2021.108722
Peer Reviewed verified by ORBi

Jehasse, K., Massotte, L., Hartmann, S., Vitello, R., Ringlet, S., Lakaye, B., Liégeois, J.-F., Roeper, J., & Seutin, V. (22 May 2020). On the path to understanding pacemaking of dopaminergic neurons [Poster presentation]. Virtual Dopamine Meeting.

Contact ORBi